Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.57 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.55 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.53 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.50 |
| ▸ | HTR3B | O95264 | 1/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | HTR3A | P46098 | 1/20 | 0.50 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.50 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28134647 | 0.98 | MBTD1 (0.55) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| Hydrochloric Acid SCHEMBL1920820 | 0.98 | MBTD1 (0.55) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| SCHEMBL28940844 | 0.98 | MBTD1 (0.55) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| SCHEMBL3900451 | 0.88 | HRH3 (0.51) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| SCHEMBL3436548 | 0.87 | NOTUM (0.59) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| SCHEMBL6398487 | 0.87 | NOTUM (0.59) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| SCHEMBL17392707 | 0.87 | NOTUM (0.59) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| Pivalate SCHEMBL27800311 | 0.86 | GPR119 (0.54) | MBTD1L3MBTL3L3MBTL1SLC18A3NOTUM | |
| SCHEMBL24008584 | 0.84 | DRD2 (0.49) | MBTD1L3MBTL3L3MBTL1SLC18A3SIGMAR1 | |
| SCHEMBL3891049 | 0.83 | LTA4H (0.60) | MBTD1L3MBTL3L3MBTL1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117106741-A | Alcohol dehydrogenase mutant and application thereof | 清华大学 | 2023-11-24 | — | — | CN | claimed |
| CN-113122050-A | Quantum dot ink and preparation method of quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-110483376-B | Synthesis method of intermediate N-phenyl-4-piperidone | 山西智创药研科技有限公司 | 2020-11-03 | — | — | CN | claimed |
| CN-110294707-A | Environmentally friendly fluoroquinolone molecule derivative preparation method | 华北电力大学 | 2019-10-01 | — | — | CN | claimed |
| CN-105705489-B | Compound as immunomodulator | 百时美施贵宝公司 | 2019-04-26 | — | — | CN | claimed |
| CN-108997242-A | Substituted phenyl pyrazole quinoline ketone derivatives and preparation and application | 浙江大学 | 2018-12-14 | — | — | CN | claimed |
| US-12630562-B2 | Piperidylurea compounds and methods of use thereof | ARCUS BIOSCIENCES, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4717317-A2 | N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION | C4 Therapeutics, Inc. (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20260070884-A1 | Inhibitors of Dihydroceramide Desaturase for Treating Disease | CENTAURUS THERAPEUTICS (US) | 2026-03-12 | — | — | US | disclosed |
| EP-3641762-B1 | N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION | C4 THERAPEUTICS INC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260042777-A1 | PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260015362-A1 | N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION | C4 THERAPEUTICS, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-12441740-B2 | N/O-linked degrons and degronimers for protein degradation | C4 THERAPEUTICS, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| EP-0513247-A4 | SIDE CHAIN COPOLYMERS EXHIBITING NONLINEAR OPTICAL RESPONSE | — | 1993-02-03 | — | — | EP | disclosed |
| EP-0513247-A1 | SIDE CHAIN COPOLYMERS EXHIBITING NONLINEAR OPTICAL RESPONSE | HOECHST CELANESE CORPORATION (US) | 1992-11-19 | — | — | EP | disclosed |
| WO-1991012462-A1 | SIDE CHAIN COPOLYMERS EXHIBITING NONLINEAR OPTICAL RESPONSE | HOECHST CELANESE CORPORATION (US) | 1991-08-22 | — | — | WO | disclosed |
| US-5041509-A | Side chain copolymers exhibiting nonlinear optical response | CORNING INCORPORATRED | 1991-08-20 | — | — | US | disclosed |
| US-4337341-A | 4a-Aryl-octahydro-1H-2-pyrindines | ELI LILLY AND COMPANY (US) | 1982-06-29 | — | — | US | disclosed |
| EP-0002937-A1 | Novel pyrindines and their preparation, formulations and use | ELI LILLY AND COMPANY (US) | 1979-07-11 | — | — | EP | disclosed |
| US-4132709-A | [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor | AYERST, MCKENNA & HARRISON, LTD. (CA) | 1979-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441740-B2 | N/O-linked degrons and degronimers for protein degradation | CRBN, CBL, STUB1 | MBTD1 3581/4885L3MBTL3 1434/4885L3MBTL1 1133/4885 |
| US-20260070884-A1 | Inhibitors of Dihydroceramide Desaturase for Treating Disease | CERS2, DEGS1, CERT1 | MBTD1 4556/4885L3MBTL3 3290/4885L3MBTL1 1806/4885 |
| US-20260015362-A1 | N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION | CRBN, CBLC, CBL | MBTD1 3973/4885L3MBTL3 1479/4885L3MBTL1 1110/4885 |
| US-12630562-B2 | Piperidylurea compounds and methods of use thereof | CLIC1, HCCS, CNR1 | MBTD1 4730/4885L3MBTL3 3068/4885L3MBTL1 2974/4885 |
| US-20260042777-A1 | PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF | CBR1, CLIC1, RER1 | MBTD1 4678/4885L3MBTL3 2853/4885L3MBTL1 2908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.